BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4127418)

  • 1. [Treatment of the carcinoma of the prostate with gestagens (author's transl)].
    Popelier G
    Urologe A; 1973 May; 12(3):134-9. PubMed ID: 4127418
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone therapy of prostatic neoplasms].
    Frick J; Marberger H; Swoboda HP
    Urologe; 1971 May; 10(3):117-9. PubMed ID: 4104209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gestagens: a new method of hormonal therapy in benign prostatic hypertrophy].
    Vernet D
    Urol Int; 1970; 25(3):263-8. PubMed ID: 4112432
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical effect of chlormadinone acetate on carcinoma of the prostate (author's transl)].
    Matsuoka M; Mayuzumi T; Shida K
    Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1010-23. PubMed ID: 6162051
    [No Abstract]   [Full Text] [Related]  

  • 5. [High-dose chlormadinone in the treatment of malignant tumors. An analysis of 20 cases (author's transl)].
    Chen YS; Zhang TJ; Zhang SS; Chen YX
    Zhonghua Zhong Liu Za Zhi; 1980 Dec; 2(4):288-91. PubMed ID: 6170502
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.
    Geller J; Fruchtman B; Meyer C; Newman H
    J Clin Endocrinol Metab; 1967 Apr; 27(4):556-60. PubMed ID: 4164338
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differential diagnosis and treatment of hirsutism].
    Husmann F
    Munch Med Wochenschr; 1967 Oct; 109(41):2124-8. PubMed ID: 4174078
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of hormone studies for the control of the treatment effectiveness of squamous-cell cancer of the lung].
    Chirvina ED; Tiutiunova AM; Kartashov SZ
    Vopr Onkol; 1980; 26(11):91-5. PubMed ID: 7456432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
    Plante M; Lapointe S; Labrie F
    J Steroid Biochem; 1988 Jul; 31(1):61-4. PubMed ID: 2456423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiandrogen therapy of acne, falling hair and hirsutism (author's transl)].
    Kaiser E
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):975-80. PubMed ID: 6158681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary 17-ketosteroid excretion and serum 17-hydroxycorticosteroid levels during treatment of prostate cancer patients].
    Portnoĭ AS; Parfent'eva LN
    Vopr Onkol; 1969; 15(12):30-4. PubMed ID: 5372969
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histomorphological investigations of endometrial carcinoma during progestional treatment with chlormadione acetate (author's transl)].
    Boquoi E; Kreuzer G
    Geburtshilfe Frauenheilkd; 1973 Sep; 33(9):697-708. PubMed ID: 4129072
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary hormone metabolite levels in patients with cancer of the breast, prostate and lung.
    Marmorston J
    Ann N Y Acad Sci; 1966 Jan; 125(3):959-73. PubMed ID: 5223416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fundamental and clinical study on antiandrogens--androgen-dependency of prostatic tumors and clinical application of antiandrogens (author's transl)].
    Shida K
    Horumon To Rinsho; 1980 Aug; 28(8):899-928. PubMed ID: 6161722
    [No Abstract]   [Full Text] [Related]  

  • 15. [Endocrinological study on prostatic carcinoma: anti-androgenic therapy and extragonadal androgens (analysis of 17-ketosteroid fractions by gas-liquid chromatography].
    Ishibashi H
    Nihon Hinyokika Gakkai Zasshi; 1968 May; 59(5):351-73. PubMed ID: 4302504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of steroids in a 4 1/2-year-old boy with precocious puberty caused by adrenal gland carcinoma].
    Gleispach H; Alcaniz Cerrando JJ; Barcelo Lucerga B; Salto Hernandez L; Glatzl J
    Padiatr Grenzgeb; 1974; 13(4):265-9. PubMed ID: 4457768
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormone excretion in prostatic cancer: the early and late effects of endocrine treatment on urinary oestrogens, 17-ketosteroids and 17-ketogenic steroids.
    BULBROOK RD; FRANKS LM; GREENWOOD FC
    Acta Endocrinol (Copenh); 1959 Aug; 31():481-99. PubMed ID: 13805840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma].
    Sasagawa I; Satomi S; Katayama T
    Gan No Rinsho; 1989 May; 35(6):767-71. PubMed ID: 2470932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on extragonadal androgen: hormonal changes of the prostatic cancer patients on antiandrogenic therapy after orchiectomy.
    Fukuda Y
    Kobe J Med Sci; 1968 Mar; 14(1):1-23. PubMed ID: 5674440
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone therapy of prostatic cancer (author's transl)].
    Altwein JE; Jacobi GH
    Urologe A; 1980 Nov; 19(6):350-7. PubMed ID: 7193368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.